LIANG XUE,William K. Chan,Stan W. Linnet,Timothy N. Linnet
申请号：
US13163658
公开号：
US20120322816A1
申请日:
2011.06.17
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The teachings provided herein generally relate to compositions comprising rutaecarpine derivatives that activates CYP1A2 through enzyme induction. The uses for such a derivative can include removing caffeine from a subject, improving sleep, treating insomnia, treating caffeine toxicity, treating caffeine addiction and withdrawal symptoms, and the like. Caffeine is just one example of a substrate that can be removed using the derivatives taught herein, and other examples, including theophylline, are provided herein.
